These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10464491)

  • 1. [Morphine poisoning in chronic kidney failure. Morphine-6-glucuronide as a pharmacologically active morphine metabolite].
    Dubs A; Wiedemeier P; Caduff B
    Dtsch Med Wochenschr; 1999 Jul; 124(30):896-8. PubMed ID: 10464491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide.
    Klimas R; Mikus G
    Br J Anaesth; 2014 Dec; 113(6):935-44. PubMed ID: 24985077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of intrathecal morphine overdose.
    Yilmaz A; Sogut A; Kilinc M; Sogut AG
    Neurol India; 2003 Sep; 51(3):410-1. PubMed ID: 14652457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near fatal intoxication with controlled-release morphine tablets in a depressed woman.
    Westerling D; Säwe J; Eklundh G
    Acta Anaesthesiol Scand; 1998 May; 42(5):586-9. PubMed ID: 9605377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine-6-glucuronide: morphine's successor for postoperative pain relief?
    van Dorp EL; Romberg R; Sarton E; Bovill JG; Dahan A
    Anesth Analg; 2006 Jun; 102(6):1789-97. PubMed ID: 16717327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose intrathecal naloxone to enhance intrathecal morphine analgesia: a case report.
    Hamann S; Sloan PA; Witt W
    J Opioid Manag; 2008; 4(4):251-4. PubMed ID: 18837205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous bolus of ultra-low-dose naloxone added to morphine does not enhance analgesia in emergency department patients.
    Bijur PE; Schechter C; Esses D; Chang AK; Gallagher EJ
    J Pain; 2006 Feb; 7(2):75-81. PubMed ID: 16459272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PBPK-PD model for predicting morphine pharmacokinetics, CNS effects and naloxone antagonism in humans.
    Mu RJ; Liu TL; Liu XD; Liu L
    Acta Pharmacol Sin; 2024 Aug; 45(8):1752-1764. PubMed ID: 38570601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine.
    Wu D; Kang YS; Bickel U; Pardridge WM
    Drug Metab Dispos; 1997 Jun; 25(6):768-71. PubMed ID: 9193881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma.
    Tsui BC; Davies D; Desai S; Malherbe S
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):678-80. PubMed ID: 15454842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Practical problems associated with long-term opioid therapy].
    Bell RF
    Tidsskr Nor Laegeforen; 1997 May; 117(12):1786-7. PubMed ID: 9213988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of morphine with naloxone precipitates haloperidol-induced extrapyramidal side effects.
    Guo SL; Lin CJ; Huang HH; Chen LK; Sun WZ
    J Pain Symptom Manage; 2006 May; 31(5):391-2. PubMed ID: 16716869
    [No Abstract]   [Full Text] [Related]  

  • 13. Intrathecal morphine for neuropathic pain in a pregnant cancer patient.
    Wen YR; Hou WY; Chen YA; Hsieh CY; Sun WZ
    J Formos Med Assoc; 1996 Mar; 95(3):252-4. PubMed ID: 8857260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal absorption and stability of morphine 6-glucuronide in different physiological compartments of the rat.
    Stain-Texier F; Sandouk P; Scherrmann JM
    Drug Metab Dispos; 1998 May; 26(5):383-7. PubMed ID: 9571218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral morphine overdose in a cancer patient antagonized by prolonged naloxone infusion.
    Upadhyay S; Jain R; Chauhan H; Gupta D; Mishra S; Bhatnagar S
    Am J Hosp Palliat Care; 2008; 25(5):401-5. PubMed ID: 18539764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treament of morphine-induced constipation with oral naloxone].
    Latasch L; Zimmermann M; Eberhardt B; Jurna I
    Anaesthesist; 1997 Mar; 46(3):191-4. PubMed ID: 9163262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finding an optimal dose: considerations in accurate opioid dispensing.
    Dunn EB; Wolfe JJ
    Vet Hum Toxicol; 2000 Feb; 42(1):36-8. PubMed ID: 10670085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analgesic effect of morphine and its metabolites administered by an intracerebroventricular route].
    Serrié A
    Bull Acad Natl Med; 1995 Jun; 179(6):1237-52; discussion 1252-3. PubMed ID: 8542351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid and plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in patients before and after initiation of intracerebroventricular morphine for cancer pain management.
    Smith MT; Wright AW; Williams BE; Stuart G; Cramond T
    Anesth Analg; 1999 Jan; 88(1):109-16. PubMed ID: 9895076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone infusion and post-hysterectomy morphine consumption: a double-blind, placebo-controlled study.
    Movafegh A; Shoeibi G; Ansari M; Sadeghi M; Azimaraghi O; Aghajani Y
    Acta Anaesthesiol Scand; 2012 Nov; 56(10):1241-9. PubMed ID: 22946762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.